Mergers & Acquisitions ·
iRhythm completes acquisition of VitalConnect for $237.5M in cash and stock
IRTCiRhythm Holdings, Inc.
iRhythm Holdings, Inc. completed its previously announced acquisition of Vital Connect, Inc., a leader in wearable biosensor technology and ambulatory cardiac monitoring. The transaction consideration consisted of $237.5 million in cash, subject to customary adjustments, funded from iRhythm's balance sheet, plus up to 423,334 shares issued at closing. Additionally, iRhythm provided $10.0 million of working capital funding between signing and closing. The acquisition expands iRhythm’s cardiac monitoring portfolio into inpatient and hospital-to-home settings, adding mobile cardiac telemetry capabilities. The deal is expected to enhance revenue growth starting in 2027 while preserving the company's adjusted EBITDA margin target of 15% for that year. iRhythm will provide updated financial guidance inclusive of VitalConnect during its third-quarter earnings call on November 5, 2026. iRhythm is a leading digital health care company specializing in wearable biosensors and cloud-based data analytics for cardiac monitoring.